Pain relief techniques for breast cancer surgeries
Locoregional Blocks for Breast Cancer Surgeries
This study tests different pain relief methods for women having breast surgery to see which one helps them feel better after the operation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | National Cancer Institute, Egypt Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06230575 on ClinicalTrials.gov |
What this trial studies
This study evaluates various locoregional anesthesia techniques to provide effective postoperative analgesia for women undergoing breast surgeries. It focuses on methods such as erector spinae block, retrolaminar block, serratus anterior block, and pectoral nerve block to manage acute pain. The goal is to determine the most effective approach for pain control in this patient population, enhancing recovery and comfort after surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are female breast cancer patients aged 18 to 65.
Not a fit: Patients with coagulation defects or abnormal kidney and liver function tests may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve pain management for breast cancer surgery patients, leading to better recovery experiences.
How similar studies have performed: Other studies have shown promising results with similar locoregional anesthesia techniques for postoperative pain management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * female cancer breast patient * age from 18- 65 Exclusion Criteria: * coagulation defect * Patient refusal * abnormal kidney and or liver function tests
Where this trial is running
Cairo
- Walaa Y Elsabeeny — Cairo, Egypt (Recruiting)
Study contacts
- Principal investigator: Walaa Y Elsabeeny, MD — Assistant professor of Anesthesia, Surgical critical care and Pain Management, National Cancer Institute, Cairo University
- Study coordinator: Walaa Y Elsabeeny, MD
- Email: Walaa.elsabeeny@nci.cu.edu.eg
- Phone: +201007798466
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.